From bonds to energy to emerging markets, an examination of what might be hot and what might not.
BB- and B-rated bonds have performed well lately, but CCC-rated bonds are a different story -- this divergence hasn't happened in nearly two decades and it gives clues about what to expect for 2020.
Amgen is finally making an expected splash out of its cash pile, but questions are abounding about the cost paid for Celgene's Otezla.
General Electric's CEO isn't inspiring much confidence.
KHC has a big problem on its balance sheet.
Where China needs to defend the renminbi from falling too far.
If money's already tight, long-term rates may have already peaked.
From overweighting dividend stocks to avoiding high-yield bonds, this is how I'm playing things here.
A bearishly biased out-of-the-money long put 'shooter' expiring in January.
A road trip reveals some surprising answers.